MX2014002204A - Metodo para reducir el potencial tromboembolico de una composicion de inmunoglobulina derivada de plasma. - Google Patents
Metodo para reducir el potencial tromboembolico de una composicion de inmunoglobulina derivada de plasma.Info
- Publication number
- MX2014002204A MX2014002204A MX2014002204A MX2014002204A MX2014002204A MX 2014002204 A MX2014002204 A MX 2014002204A MX 2014002204 A MX2014002204 A MX 2014002204A MX 2014002204 A MX2014002204 A MX 2014002204A MX 2014002204 A MX2014002204 A MX 2014002204A
- Authority
- MX
- Mexico
- Prior art keywords
- reducing
- immunoglobulin composition
- plasma
- derived immunoglobulin
- factor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
- C07K16/065—Purification, fragmentation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Transplantation (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
La presente invención describe métodos para reducir la actividad amidolítica y anti-complemento (ACA) de una composición de inmunoglobulina a través del uso de cromatografía de intercambio catiónico. En una modalidad específica, la invención provee métodos para reducir el contenido de Factor XI y/o Factor XIa y/o ACA en una composición de inmunoglobulina por recolección la porción principal de un eluato de intercambio catiónico. La presente invención también provee una composición de inmunoglobulina con niveles reducidos de actividad amidolítica, Factor XI y/o Factor XIa y/o ACA.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161527974P | 2011-08-26 | 2011-08-26 | |
PCT/US2012/052567 WO2013033042A1 (en) | 2011-08-26 | 2012-08-27 | Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2014002204A true MX2014002204A (es) | 2014-06-11 |
MX349005B MX349005B (es) | 2017-07-06 |
Family
ID=46970397
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2014002204A MX349005B (es) | 2011-08-26 | 2012-08-27 | Metodo para reducir el potencial tromboembolico de una composicion de inmunoglobulina derivada de plasma. |
Country Status (20)
Country | Link |
---|---|
US (1) | US9403899B2 (es) |
EP (1) | EP2748193B1 (es) |
JP (1) | JP6165143B2 (es) |
KR (1) | KR101949553B1 (es) |
CN (1) | CN103874708B (es) |
AR (1) | AR087953A1 (es) |
AU (1) | AU2012300220C1 (es) |
BR (1) | BR112014004445B1 (es) |
CA (1) | CA2846599A1 (es) |
CL (1) | CL2014000480A1 (es) |
CO (1) | CO6920256A2 (es) |
EA (1) | EA030251B1 (es) |
ES (1) | ES2624485T3 (es) |
HK (1) | HK1199267A1 (es) |
IL (1) | IL231083B (es) |
MX (1) | MX349005B (es) |
MY (1) | MY165164A (es) |
SG (1) | SG11201400233TA (es) |
TW (1) | TWI610937B (es) |
WO (1) | WO2013033042A1 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2013203043B2 (en) * | 2013-03-15 | 2016-10-06 | Takeda Pharmaceutical Company Limited | Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs |
ES2785375T3 (es) | 2014-03-11 | 2020-10-06 | Green Cross Holdings Corp | Procedimiento de purificación de inmunoglobulina |
CA2941232C (en) * | 2014-03-11 | 2020-08-25 | Green Cross Holdings Corporation | Method for purifying immunoglobulin |
EP3275897A1 (en) * | 2016-07-27 | 2018-01-31 | Biotest AG | Process for preparing immunoglobulin compositions |
KR101941974B1 (ko) * | 2016-11-18 | 2019-01-24 | 주식회사 녹십자 | 혈장 단백질 정제시 fxi의 제거방법 |
EP3638693A4 (en) * | 2017-06-12 | 2021-04-14 | Kamada Ltd | IMMUNOGLOBULIN COMPOSITIONS AND PROCESS FOR THEIR PREPARATION |
WO2023215722A1 (en) * | 2022-05-02 | 2023-11-09 | Takeda Pharmaceutical Company Limited | Methods of preparing cohn pool concentrate from blood plasma through ultrafiltration |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE348942B (es) | 1970-06-02 | 1972-09-18 | Statens Bakteriologiska Labor | |
JPS5598117A (en) | 1979-01-17 | 1980-07-25 | Chemo Sero Therapeut Res Inst | Purification of gamma-globulin derivative |
US4639513A (en) | 1984-02-02 | 1987-01-27 | Cuno Inc. | Intravenously injectable immunoglobulin G (IGG) and method for producing same |
DK166763B1 (da) | 1983-03-16 | 1993-07-12 | Immuno Ag | Immunoglobulin-g-holdig fraktion |
US4482483A (en) | 1983-04-06 | 1984-11-13 | Armour Pharmceutical Company | Composition of intravenous immune globulin |
DE3483784D1 (de) | 1984-07-07 | 1991-01-31 | Woelm Pharma Gmbh & Co | Verfahren zur herstellung von gamma-globulin zur intravenoesen anwendung. |
DE3640513A1 (de) | 1986-11-27 | 1988-06-09 | Biotest Pharma Gmbh | Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates |
DE3641115A1 (de) | 1986-12-02 | 1988-06-16 | Lentia Gmbh | Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins |
US5177194A (en) | 1990-02-01 | 1993-01-05 | Baxter International, Inc. | Process for purifying immune serum globulins |
FR2706466B1 (fr) | 1993-06-14 | 1995-08-25 | Aetsrn | Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré. |
ES2129076T5 (es) | 1993-12-27 | 2003-05-16 | Zlb Bioplasma Ag | Procedimiento para la preparacion de un concentrado de inmunoglobulina g anti-d y composicion farmaceutica que lo contiene. |
GB9610992D0 (en) | 1996-05-24 | 1996-07-31 | Glaxo Group Ltd | Concentrated antibody preparation |
US6162904A (en) | 1997-12-24 | 2000-12-19 | Alpha Therapeutic Corporation | Manufacturing method for intraveneously administrable immune globulin and resultant product |
KR100501263B1 (ko) * | 1998-06-09 | 2005-07-18 | 스태튼스 세룸 인스티튜트 | 정맥 주사용 면역글로불린의 제조 방법 및 그 외의 면역글로불린 제품 |
ES2527915T3 (es) * | 1998-06-09 | 2015-02-02 | Csl Behring Ag | Producto de inmunoglobulina G (IgG) líquido |
SE0001128D0 (sv) * | 2000-03-30 | 2000-03-30 | Amersham Pharm Biotech Ab | A method of producing IgG |
EA023382B1 (ru) * | 2009-05-27 | 2016-05-31 | Бакстер Интернэшнл Инк. | Способ получения высококонцентрированного препарата иммуноглобулина для подкожного применения |
IL212911A0 (en) | 2011-05-16 | 2011-07-31 | Omrix Biopharmaceuticals Ltd | Immunoglobulin reduced in thrombogenic contaminants and preparation thereof |
-
2012
- 2012-08-27 BR BR112014004445-7A patent/BR112014004445B1/pt active IP Right Grant
- 2012-08-27 CA CA2846599A patent/CA2846599A1/en not_active Abandoned
- 2012-08-27 SG SG11201400233TA patent/SG11201400233TA/en unknown
- 2012-08-27 WO PCT/US2012/052567 patent/WO2013033042A1/en active Application Filing
- 2012-08-27 JP JP2014527355A patent/JP6165143B2/ja active Active
- 2012-08-27 TW TW101130949A patent/TWI610937B/zh active
- 2012-08-27 US US13/595,967 patent/US9403899B2/en active Active
- 2012-08-27 KR KR1020147007936A patent/KR101949553B1/ko active IP Right Grant
- 2012-08-27 MX MX2014002204A patent/MX349005B/es active IP Right Grant
- 2012-08-27 EA EA201400273A patent/EA030251B1/ru not_active IP Right Cessation
- 2012-08-27 CN CN201280050156.XA patent/CN103874708B/zh active Active
- 2012-08-27 ES ES12768938.8T patent/ES2624485T3/es active Active
- 2012-08-27 MY MYPI2014000533A patent/MY165164A/en unknown
- 2012-08-27 AR ARP120103162A patent/AR087953A1/es active IP Right Grant
- 2012-08-27 AU AU2012300220A patent/AU2012300220C1/en active Active
- 2012-08-27 EP EP12768938.8A patent/EP2748193B1/en active Active
-
2014
- 2014-02-23 IL IL231083A patent/IL231083B/en active IP Right Grant
- 2014-02-26 CL CL2014000480A patent/CL2014000480A1/es unknown
- 2014-03-20 CO CO14060700A patent/CO6920256A2/es unknown
- 2014-12-22 HK HK14112763.4A patent/HK1199267A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
MX349005B (es) | 2017-07-06 |
CL2014000480A1 (es) | 2014-10-03 |
IL231083B (en) | 2019-06-30 |
JP2014525417A (ja) | 2014-09-29 |
BR112014004445A2 (pt) | 2017-03-28 |
TW201326192A (zh) | 2013-07-01 |
US20130058961A1 (en) | 2013-03-07 |
IL231083A0 (en) | 2014-03-31 |
CO6920256A2 (es) | 2014-04-10 |
ES2624485T3 (es) | 2017-07-14 |
TWI610937B (zh) | 2018-01-11 |
US9403899B2 (en) | 2016-08-02 |
AU2012300220A1 (en) | 2013-05-02 |
EP2748193B1 (en) | 2017-02-01 |
KR101949553B1 (ko) | 2019-02-18 |
EP2748193A1 (en) | 2014-07-02 |
CA2846599A1 (en) | 2013-03-07 |
EA201400273A1 (ru) | 2014-08-29 |
AR087953A1 (es) | 2014-04-30 |
CN103874708B (zh) | 2018-07-10 |
AU2012300220C1 (en) | 2016-11-10 |
AU2012300220B2 (en) | 2015-09-10 |
JP6165143B2 (ja) | 2017-07-19 |
HK1199267A1 (en) | 2015-06-26 |
KR20140062088A (ko) | 2014-05-22 |
SG11201400233TA (en) | 2014-08-28 |
EA030251B1 (ru) | 2018-07-31 |
MY165164A (en) | 2018-02-28 |
BR112014004445B1 (pt) | 2022-11-22 |
WO2013033042A1 (en) | 2013-03-07 |
CN103874708A (zh) | 2014-06-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX349005B (es) | Metodo para reducir el potencial tromboembolico de una composicion de inmunoglobulina derivada de plasma. | |
PH12014501108A1 (en) | Anti-il-36r antibodies | |
IN2013MU02145A (es) | ||
MX2018013128A (es) | Molecula de union al antigeno para promover la perdia de antigeno a traves de fc gamma riib. | |
PH12015501000A1 (en) | Anti-notch3 antibodies and antibody-drug conjugates | |
MX2019008065A (es) | Composiciones que comprenden anticuerpos anti-cd38 y lenalidomida. | |
MX343858B (es) | Anticuerpos anti-il-23. | |
NZ605400A (en) | Chimeric clotting factors | |
MX2013010019A (es) | Metodo para aislamiento de osteopontina utilizando alimentos concentrados. | |
MX342920B (es) | Metodo para purificar polipeptidos o inmunoconjugados activos. | |
MX368653B (es) | Anticuerpos anti-il-23p19. | |
MX2014000531A (es) | Metodos y composiciones para el tratamiento del asma usando anticuerpos anti-il-13. | |
PH12016500158A1 (en) | Methods for controlling fucosylation levels in proteins | |
SG10201907901XA (en) | Antibodies, uses & methods | |
SG10201804952QA (en) | Glucosylceramide synthase inhibitors | |
MX368474B (es) | Uso de benralizumab para mejorar síntomas de asma. | |
MY170869A (en) | Chuck for chemical vapor deposition systems and related methods therefor | |
WO2013187971A3 (en) | Macrocycles | |
NZ716205A (en) | Purification process for pth | |
MX351465B (es) | Un método para remover nitrógeno de amonio de agua con residuos orgánicos. | |
MX341733B (es) | Purificacion de inhibidor de proteasa alfa1 derivado de cultivo celular. | |
UA74021U (ru) | Способ лечения хронического вирусного гепатита с | |
EP2832871A4 (en) | METHOD FOR ELIMINATING SILVER AND METALS ADDED BY ACTIVATED CARBON AND METHOD FOR RECOVERING SILVER AND OTHER METALS | |
IN2014CN03825A (es) | ||
SE1630303A1 (en) | A new method for predicting uric acid composition in urinarystones using routine single energy computer tomography |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB | Transfer or rights |
Owner name: BAXALTA INCORPORATED |
|
FG | Grant or registration |